India’s COVID-19 caseload increased to 92.66 lakh with 44,489 new infections being reported in a day, while the recoveries surged to 86.79 lakh, the Union health ministry said on Thursday.
The country’s coronavirus tally mounted to 92,66,705, while the death toll climbed to 1,35,223 with 524 new fatalities, the ministry data updated at 8 am showed.
The COVID-19 active caseload has risen to 4,52,344, an increase of 7,598 cases from Wednesday, even though it remained below 5 lakh for the 16th consecutive day.
The active cases comprise 4.88 percent of the total caseload, the data stated.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The total number of people who have recuperated from the disease surged to 86,79,138, pushing the national recovery rate to 93.66 percent, while the COVID-19 case fatality rate stands at 1.46 percent.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7,30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, 80 lakh on October 29, and surpassed90 lakh on November 20.
According to ICMR, over 13.59 crore samples have been tested for COVID-19 till November 25, with 10,90,238 samples being tested on Wednesday.
The 524 new fatalities include 99 from Delhi, 65 from Maharashtra, 51 from West Bengal, 42 from Haryana, 31 from Punjab, 29 from Uttar Pradesh and 26 from Kerala.
A total of 1,35,223 deaths reported so far in the country includes 46,748 from Maharashtra followed by 11,714 from Karnataka, 11,655 from Tamil Nadu, 8,720 from Delhi, 8,172 from West Bengal, 7,644 from Uttar Pradesh, 6,962 from Andhra Pradesh, 4,684 from Punjab and 3,906 from Gujarat.
The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.
"Our figures are being reconciled with the Indian Council of Medical Research (ICMR),” the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.Follow our full coverage of the coronavirus pandemic here.